Currently, there are 170.42M common shares owned by the public and among those 169.06M shares have been available to trade.
Insiders at the company have transacted a total of 31 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 17 of these insider trades were purchases, accounting for 286,561 shares. Insider sales of the common stock occurred on 14 occasions, with total insider shares sold totaling 30,004 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 2.4100, up 8.68%. The company’s stock has a 5-day price change of 9.68% and 169.23% over the past three months. ESPR shares are trading -20.40% year to date (YTD), with the 12-month market performance down to -59.80% lower. It has a 12-month low price of $0.70 and touched a high of $6.74 over the same period. ESPR has an average intraday trading volume of 5.99 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.06%, 14.72%, and 58.77% respectively.
Institutional ownership of Esperion Therapeutics Inc. (NASDAQ: ESPR) shares accounts for 53.77% of the company’s 170.42M shares outstanding.
It has a market capitalization of $405.60M and a beta (3y monthly) value of 0.78. The earnings-per-share (ttm) stands at -$2.37. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.90% over the week and 12.52% over the month.
Analysts forecast that Esperion Therapeutics Inc. (ESPR) will achieve an EPS of -$0.47 for the current quarter, -$0.07 for the next quarter and -$0.34 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.62 while analysts give the company a high EPS estimate of -$0.34. Comparatively, EPS for the current quarter was -$0.76 a year ago. Earnings per share for the fiscal year are expected to increase by 42.62%, and 83.18% over the next financial year. EPS should grow at an annualized rate of 16.90% over the next five years, compared to 12.80% over the past 5-year period.
